Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Clever Smartphone Software, Boldly Going Where No Phone Has Gone Before

Read about the latest developments in smartphone software. . . . → Read More: Clever Smartphone Software, Boldly Going Where No Phone Has Gone Before

Simple Cell Programming Designed for Gene Therapies

A simpler technique using nanoscale particles was shown in lab tests to deliver messenger RNA to reprogram cells for gene therapies, including changes in T-cells in the immune system now approved to treat a type of leukemia. . . . → Read More: Simple Cell Programming Designed for Gene Therapies

The Formula For A Strong Investment Strategy

Acknowledging the key equations for success is vital for all potential investors. . . . → Read More: The Formula For A Strong Investment Strategy

Trial Shows Smartphone App Finds More Heart Disease

Results from a clinical trial show an electrocardiogram app on a smartphone detects more cases of irregular heart beats than routine office visits. . . . → Read More: Trial Shows Smartphone App Finds More Heart Disease

Students Win Prize, Start Company for Alzheimer’s Detection

A team of undergraduate students won first prize in a National Institutes of Health biomedical engineering contest for a headset device to diagnose early-stage Alzheimer’s disease. . . . → Read More: Students Win Prize, Start Company for Alzheimer’s Detection

App Screens for Liver Diseases with Eye Selfies

A computer science lab designed a smartphone app that detects tell-tale indicators of liver disease and pancreatic cancer by analyzing self-taken photos of a patient’s own eyes. . . . → Read More: App Screens for Liver Diseases with Eye Selfies

Trial Testing Nicotine Patch for Lung Inflammation

A clinical trial is underway testing a nicotine patch worn to help stop smoking as a treatment for a chronic inflammatory disease affecting the lungs. . . . → Read More: Trial Testing Nicotine Patch for Lung Inflammation

Engineered T-Cell Company Acquired for $11.9 Billion

A company developing personal cancer therapies that genetically engineer a patient’s immune system cells is being acquired in a deal valued at $11.9 billion. . . . → Read More: Engineered T-Cell Company Acquired for $11.9 Billion

Infographic – Vaccinations Changed the World

This chart, courtesy of Der Spiegel and Statista, shows how the incidence of several diseases has been reduced in the U.S. since the introduction of vaccines. . . . → Read More: Infographic – Vaccinations Changed the World

New App Promises To Provide Tailored Radiation Treatment

Using 3-D models of their patients, the app provides neurosurgeons with all the information they need for correct dosage. . . . → Read More: New App Promises To Provide Tailored Radiation Treatment